Will Korea's New Government Create Strong Biohealth Nation?

Focus On Single 'Control Tower,' Rapid Reimbursement

 
• By Jung Won Shin
  
Hyun Wook Kim, CEO of Hyun & Partners Korea
New Korean Government’s Pro-Industry Stance Raises Biopharmas’ Growth Hopes

More from South Korea

More from Asia